Semi-Annual Balance Sheet

JCR Pharmaceuticals Co.,Ltd. - Filing #7735360

Concept As at
2017-06-30
As at
2017-03-31
Semi-annual balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
5,956,000,000 JPY
5,509,000,000 JPY
Securities
300,000,000 JPY
300,000,000 JPY
Other
1,357,000,000 JPY
1,332,000,000 JPY
Current assets
21,524,000,000 JPY
20,315,000,000 JPY
Non-current assets
Property, plant and equipment
Property, plant and equipment
11,152,000,000 JPY
11,387,000,000 JPY
Land
3,882,000,000 JPY
3,882,000,000 JPY
Construction in progress
43,000,000 JPY
31,000,000 JPY
Other
Other, net
2,394,000,000 JPY
2,536,000,000 JPY
Intangible assets
Intangible assets
102,000,000 JPY
67,000,000 JPY
Investments and other assets
Investment securities
3,596,000,000 JPY
3,587,000,000 JPY
Investments and other assets
4,576,000,000 JPY
4,614,000,000 JPY
Other
1,003,000,000 JPY
1,049,000,000 JPY
Allowance for doubtful accounts
-22,000,000 JPY
-22,000,000 JPY
Non-current assets
15,831,000,000 JPY
16,069,000,000 JPY
Assets
37,355,000,000 JPY
36,385,000,000 JPY
Liabilities
Current liabilities
Short-term borrowings
1,733,000,000 JPY
1,493,000,000 JPY
Income taxes payable
298,000,000 JPY
69,000,000 JPY
Other
1,725,000,000 JPY
1,844,000,000 JPY
Current liabilities
5,799,000,000 JPY
4,706,000,000 JPY
Non-current liabilities
Non-current liabilities
3,843,000,000 JPY
4,092,000,000 JPY
Long-term borrowings
2,504,000,000 JPY
2,713,000,000 JPY
Other
415,000,000 JPY
458,000,000 JPY
Liabilities
9,643,000,000 JPY
8,799,000,000 JPY
Other liabilities
Provision for bonuses
840,000,000 JPY
525,000,000 JPY
Other liabilities
Provision for bonuses for directors (and other officers)
92,000,000 JPY
73,000,000 JPY
Net assets
Shareholders' equity
Share capital
9,061,000,000 JPY
9,061,000,000 JPY
Capital surplus
Capital surplus
10,962,000,000 JPY
10,964,000,000 JPY
Retained earnings
Retained earnings
8,265,000,000 JPY
8,149,000,000 JPY
Treasury shares
-1,470,000,000 JPY
-1,486,000,000 JPY
Shareholders' equity
26,819,000,000 JPY
26,689,000,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
576,000,000 JPY
569,000,000 JPY
Valuation and translation adjustments
616,000,000 JPY
616,000,000 JPY
Net assets
27,712,000,000 JPY
27,585,000,000 JPY
Share acquisition rights
275,000,000 JPY
279,000,000 JPY
Liabilities and net assets
37,355,000,000 JPY
36,385,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.